Suppr超能文献

Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.

作者信息

Kurgyis Zsuzsanna, Varga Rita, Sick Isabell, Lang Martin Ulrich, Ruzicka Thomas, Sárdy Miklós

出版信息

Acta Derm Venereol. 2011 Oct;91(6):716-7. doi: 10.2340/00015555-1138.

Abstract
摘要

相似文献

1
Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
Acta Derm Venereol. 2011 Oct;91(6):716-7. doi: 10.2340/00015555-1138.
2
Bosentan for digital ulcers in patients with systemic sclerosis.
J Dermatol. 2012 Jan;39(1):48-51. doi: 10.1111/j.1346-8138.2011.01299.x. Epub 2011 Sep 28.
4
Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
Arch Dermatol. 2007 Jan;143(1):125-6. doi: 10.1001/archderm.143.1.125.
6
Digital ulcers: overt vascular disease in systemic sclerosis.
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii19-24. doi: 10.1093/rheumatology/kep105.
7
Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
Australas J Dermatol. 2012 May;53(2):e32-3. doi: 10.1111/j.1440-0960.2010.00719.x. Epub 2010 Nov 29.
8
Digital ulcers and outcomes assessment in scleroderma.
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v46-7. doi: 10.1093/rheumatology/ken310.
9
Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis.
Ann Rheum Dis. 2007 Oct;66(10):1398-9. doi: 10.1136/ard.2007.073684.

引用本文的文献

1
Swift and Complete Healing of Digital Ulcers after Macitentan Treatment.
Case Rep Rheumatol. 2016;2016:1718309. doi: 10.1155/2016/1718309. Epub 2016 Nov 22.
2
Endothelin-1 levels in scleroderma patients: a pilot study.
ISRN Dermatol. 2013 Jul 30;2013:125632. doi: 10.1155/2013/125632. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验